TNDM — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Tandem Diabetes Care, Inc.
Healthcare · $18.61
5.2
/10
Neutral
How this score works →
Regime
Bullish
vs SMA200
SMA200 Distance
+4.5%
Above trend
Volatility
Normal
Average premiums
Momentum
Turning
Price direction
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care makes insulin pumps and automated delivery systems. Growth stock, no dividend, elevated beta. Volatile on FDA news, earnings, and competitive dynamics. CSP premiums are attractive, but competition from Insulet and Medtronic creates headline-driven assignment risk.
Medical Devices
Market Cap
$1.3B
Beta
1.74
52-Week Range Current: $18.61
$9.98 $29.65
Earnings
2026-05-07
32 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE